Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)

This grant supports translational research to understand how mood and psychotic disorders emerge or worsen during the menopause transition, aiming to identify targets for future treatments. It funds innovative, interdisciplinary studies of neurobiological and behavioral mechanisms, including hormone effects, symptom diagnosis, co-occurring psychiatric and menopause symptoms, and psychosocial factors.